HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132-3p.

AbstractBACKGROUND:
Dihydroquercetin (DHQ) is a potent flavonoid which has been demonstrated to have multiple biological activities including anti-inflammation activity, antioxidant activity as well as anti-cancer activity etc. Recently, many studies have focused on the antioxidant activity of DHQ. However, the use of the anti-inflammation activity of DHQ in acute lung injury (ALI) has not been reported.
METHODS:
Cell viability was examined by CCK-8 assay. The relative expression of miR-132-3p, FOXO3 were detected by qPCR. The levels of TNF-α, IL-6 and IL-1β were detected using enzyme-linked immunosorbent assay. The amount of apoptosis cells was detected by flow cytometry. The protein levels of Bcl-2, Bax, p-p65 and p-IκBα were measured by western blot.
RESULTS:
We found that DHQ-induced the expression of miR-132-3p in LPS-induced ALI. Overexpression of miR-132-3p resulted in the inhibition of FOXO3 expression and then suppressed FOXO3-activated NF-κB pathway, attenuating LPS-induced inflammatory response and apoptosis.
CONCLUSION:
We demonstrated FOXO3 to be a target of miR-132-3p, and DHQ could induce the expression of miR-132-3p, relieving LPS-induced ALI via miR-132-3p/FOXO3/NF-κB axis, providing a promising therapeutic target for ALI.
AuthorsJian-Hua Liu, Liang Cao, Chang-Hong Zhang, Chen Li, Zhi-Hua Zhang, Qi Wu
JournalPulmonary pharmacology & therapeutics (Pulm Pharmacol Ther) Vol. 64 Pg. 101934 (10 2020) ISSN: 1522-9629 [Electronic] England
PMID32805387 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • FOXO3 protein, human
  • Forkhead Box Protein O3
  • Lipopolysaccharides
  • MIRN132 microRNA, human
  • MicroRNAs
  • NF-kappa B
  • Quercetin
  • taxifolin
Topics
  • Acute Lung Injury (chemically induced, drug therapy)
  • Forkhead Box Protein O3 (genetics)
  • Humans
  • Lipopolysaccharides (toxicity)
  • MicroRNAs (genetics)
  • NF-kappa B
  • Quercetin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: